“Steroid-Refractory Chronic Graft-Versus-Host Disease Treated With Ruxolitinib: A Narrative Review of Symptom Burden and Return to Daily Life”. Journal of Clinical Case Studies and Reviews 4, no. 1 (November 4, 2023): 31–36. Accessed October 30, 2026. https://pragmajournals.org/index.php/JCCSR/article/view/311.